Advertisement

Topics

UK's Destiny Pharma Taps AIM Market to Fund 'Superbug' Drugs

12:23 EDT 21 Aug 2017 | Medscape

British biotech firm Destiny Pharma is aiming to raise more than 10 million pounds ($12.9 million) of new equity to develop drugs that target antibiotic-resistant bacterial infections, or superbugs, in hospitals, it said on Friday.
Reuters Health Information

Original Article: UK's Destiny Pharma Taps AIM Market to Fund 'Superbug' Drugs

NEXT ARTICLE

More From BioPortfolio on "UK's Destiny Pharma Taps AIM Market to Fund 'Superbug' Drugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...